Maximize Returns with AI-Powered VIR Insights

AI VIR Forecast

Price Forecast:

Bearish <-> Bullish

Bullish Case: Positive trial results or FDA approvals for VIR's hepatitis treatments could significantly uplift market sentiment and drive stock price above $10, reversing current downtrends.

Bearish Case: Continued insider selling and adverse trial results may create further market skepticism, potentially driving the stock below $7 as investor confidence wanes.

Potential Outcomes:

1. Positive VIR trial results (40% chance).

2. Insider selling dampens stock (30% chance).

3. Stagnation due to mixed signals (30% chance).

Trading Oracle: Sign Up to access trading oracle trade ideas.

September 15, 2024

Vir Biotechnology Forecast

VIR Vir Biotechnology

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with VIR

SEE Sealed Air (0.71)

RH RH - (0.68)

RXRX Recursion Pharmaceuticals (0.67)

ARKG ARK Investment Management LLC - ARK Genomic Revolution (0.66)

W Wayfair (0.6)

Uncorrelated Assets

Assets with little price relationship to VIR

RGLD Royal Gold (-0.0)

AEM Agnico Eagle Mines (-0.0)

TSLA Tesla (-0.0)

BOIL ProShares Ultra Bloomberg Natural Gas (0.0)

PENN Penn National Gaming (0.0)

Anticorrelated Assets

Assets that tend to move strongly against VIR

TBT PowerShares UltraShort Lehman 20+ Yea (-0.33)

UVXY ProShares Ultra VIX Short-Term Futures (-0.33)

SPXU ProShares UltraPro Short S&P 500 (-0.35)

UUP Invesco DB US Dollar Index Bullish (-0.43)

SARK Tuttle Capital Short Innovation (-0.49)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.